Findings

What do systematic reviews say?

4 questions · 5 findings · 1 reviews · Common Mental Disorders

Sort:Best matchNewest Highest certainty Download CSV

No studies found 1 · 20%GRADE not reported 0 · 0%Very low 0 · 0%Low 0 · 0%Moderate 2 · 40%High 2 · 40%

Metformin vs placebo

Diabetes · Adults with mental disorders in low‐ and middle‐income countries

The review found no eligible studies for this question.

1 finding from 1 review

Interventions for preventing type 2 diabetes in adults with mental disorders in low‐ and middle‐income countries 2021 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found

Metformin vs placebo

Drop‐out Objective · Adults with mental disorders in low‐ and middle‐income countries

Metformin showed no clear difference in drop‐outs (12 to 14 weeks) compared with placebo (moderate certainty).

1 finding from 1 review

Interventions for preventing type 2 diabetes in adults with mental disorders in low‐ and middle‐income countries 2021 · Cochrane Headline outcomes only
RR 1.22 [0.09, 16.35]
3 studies · 158 participants
Moderate

Metformin vs placebo

Fasting blood glucose (mg/dL) · Adults with mental disorders in low‐ and middle‐income countries

2 findings from 1 review

Interventions for preventing type 2 diabetes in adults with mental disorders in low‐ and middle‐income countries 2021 · Cochrane Headline outcomes only
no estimate extracted
3 studies · 173 participants
Moderate
Interventions for preventing type 2 diabetes in adults with mental disorders in low‐ and middle‐income countries 2021 · Cochrane Headline outcomes only
no estimate extracted
2 studies · 91 participants
High

Metformin vs placebo

Body‐mass index (BMI) · Adults with mental disorders in low‐ and middle‐income countries

1 finding from 1 review

Interventions for preventing type 2 diabetes in adults with mental disorders in low‐ and middle‐income countries 2021 · Cochrane Headline outcomes only
no estimate extracted
5 studies · 264 participants
High